Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 16, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 16th, 2023
Eric Joseph of JP Morgan, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $12 to $8 on, Mar 16th, 2023.
Eric has made no other calls on AVIR in the last 4 months.
There are 2 other peers that have a rating on AVIR. Out of the 2 peers that are also analyzing AVIR, 1 agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Roanna Ruiz of "SVB Leerink" Maintained at Hold with Decreased Target to $6 on, Friday, January 27th, 2023
This is the rating of the analyst that currently disagrees with Eric
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $4 on, Tuesday, January 24th, 2023
